|
Dr. Dan Lebovic is an associate professor in the University of Wisconsin-Madison Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility. He is the medical director of Generations Fertility Care. Dr. Lebovic earned his medical degree from George Washington University and completed his fellowship training in reproductive endocrinology and infertility at the University of California, San Francisco. Dr. Lebovic specializes in female infertility, endometriosis and recurrent pregnancy loss.
Dr. Lebovic provides a wide range of services including:
| UW Health Clinics |
|
Generations Fertility Care
|
 (608) 265-0300
(800) 323-8942
|
UW Hospital and Clinics
|
Map
|
| Procedures |
|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Controlled Ovarian Hyperstimulation, Endometriosis Surgery, In Vitro Fertilization (IVF), Infertility Testing and Evaluation, Intra-uterine insemination (IUI), Laparoscopic Tubal Reversal, Laparoscopy, Office Hysteroscopy, Operative Hysteroscopy, Robotic Myomectomy, Sperm Cryopreservation, Uterine Abnormalities and Associated Surgeries, Uterine Septum Resection
|
| Languages Spoken |
|
English
|
|
Medical interpreters are available to help
patients communicate with hospital and clinic staff.
For more information, please contact
interpreter services at (608) 262-9000.
|
|
Professional Certifications and Education
|
| Board Certification |
Obstetrics & Gynecology
Reproductive Endocrinology & Infertility
|
| Fellowship |
Reproductive Endocrinology and Infertility at University of California, San Francisco
|
| Residency |
University of Virginia, Charlottesville, VA
|
| Internship |
Dartmouth Hitchcock Medical Center, Lebanon, NH
|
| Medical School |
George Washington University, Washington, D.C., 1992
|
|
Hospital Affiliations
|
| Primary Affiliation(s) |
University of Wisconsin Hospital and Clinics
|
| Secondary Affiliation(s) |
Meriter Hospital
|
| Research |
Dr. Lebovic's primary research centers on the immunobiology of endometriosis. He is conducting basic science, animal model and clinical trials in novel treatments for the disease. In particular, he is investigating the utility of using thiazolidinediones in endometriosis in addition to participating in an international multi-center study on the health economics of the diagnosis and management of endometriosis. The hope is that such a medicine could be useful both for treating endometriosis-induced pains as well as allow women to conceive. |
|
